Raymond Jang

Raymond is a Rask Investment Analyst. He has extensive experience in analysing and investigating businesses from his roles at a national accounting firm and at ASIC. Raymond is a Chartered Accountant and holds a Bachelor of Commerce from the University of NSW. His curiosity about the world and drive to find high-quality businesses is what gets him out of bed every morning. Outside of writing and investing, you will find Raymond playing football in a cage (trust us, it’s more fun than it sounds) or at a park. If you enjoyed his analysis, check out our Rask services. You can connect with Raymond on Twitter or LinkedIn.

The best thing a human being can do is to help another human being know more.

Raymond Jang's latest insights

ASX Growth Shares

REA Group (ASX:REA) vs Domain (ASX:DHG)

REA Group Limited (ASX: REA) and Domain Holdings Australia Ltd (ASX: DHG) absolutely dominate the Aussie property listing space. But how come one is much bigger than the other?

ASX Growth Shares

Eyes on the ResMed (ASX:RMD) share price

The ResMed CDI (ASX: RMD) share price is in the spotlight as it released its Q3 update. How will this update affect the ResMed share price? 

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Skip to content